Diclofenac epolamine patch

DRUG2 trials

Sponsors

Northwestern University, University of Maryland, Baltimore

Conditions

BioavailabilityBreast Cancer

Early Phase 1

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

CompletedNCT01380353

Northwestern UniversityBreast Cancer

Start: 2011-06-30End: 2012-11-12Updated: 2020-02-19

Evaluation of Bioavailability of Diclofenac Dermal Products

CompletedNCT03145259

University of Maryland, BaltimoreBioavailability

Start: 2017-04-19End: 2020-05-15Updated: 2020-06-30